OTC Markets OTCQB - Delayed Quote USD

Cryomass Technologies Inc. (CRYM)

Compare
0.0315 +0.0115 (+57.50%)
At close: 3:46 PM EDT
Loading Chart for CRYM
DELL
  • Previous Close 0.0200
  • Open 0.0210
  • Bid 0.0315 x --
  • Ask 0.0325 x --
  • Day's Range 0.0210 - 0.0379
  • 52 Week Range 0.0150 - 0.0896
  • Volume 539,191
  • Avg. Volume 163,069
  • Market Cap (intraday) 7.411M
  • Beta (5Y Monthly) 0.26
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0400
  • Earnings Date Nov 18, 2024 - Nov 22, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Cryomass Technologies Inc., together with its subsidiaries, develops and licenses equipment to refine harvested cannabis, hemp, and other premium crops in the United States. It offers CryoSift Separator, which capture intact cannabis and hemp trichomes. The company was formerly known as Andina Gold Corp. and changed its name to Cryomass Technologies Inc. in August 2021. Cryomass Technologies Inc. was incorporated in 2011 and is headquartered in Denver, Colorado.

cryomass.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CRYM

View More

Performance Overview: CRYM

Trailing total returns as of 10/22/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CRYM
26.14%
S&P 500
22.67%

1-Year Return

CRYM
64.39%
S&P 500
38.52%

3-Year Return

CRYM
94.08%
S&P 500
28.60%

5-Year Return

CRYM
95.63%
S&P 500
94.60%

Compare To: CRYM

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CRYM

View More

Valuation Measures

Annual
As of 10/21/2024
  • Market Cap

    4.82M

  • Enterprise Value

    7.53M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    132.72

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    229.99

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -241.56%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    32.74k

  • Net Income Avi to Common (ttm)

    -9.17M

  • Diluted EPS (ttm)

    -0.0400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    497.9k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    141.01k

Research Analysis: CRYM

View More

Company Insights: CRYM

Research Reports: CRYM

View More

People Also Watch